News

Presentation at the ICS 2024

Dec 11, 2024

Presentation at the Congress of the ICS 2024 (International Continence Society) in  Madrid, Spain, 23-25 October, 2024. Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:  “EG110A, a novel non-replicative HSV1-derived vector expressing the light chain of botulinum toxin F, shows dose-dependent efficacy in an acute intravesical capsaicin rat model”. Ratelade J,…

Read More

Presentation at the ESSM 2024

Jun 13, 2024

Pelvipharm at the Congress of the ESSM (European Society for Sexual Medicine) in Bari, Italy, 8-10 February, 2024.   François Giuliano will present one abstract during the podium session entitled “Basic science”:    “LIB-01, a novel promising oral drug under development for the treatment of erectile dysfunction (ED) – a summary of nonclinical studies”. F. Giuliano, D. Gorny, M. Razanakolona,…

Read More

Presentation at the SMSNA 2023

Sep 27, 2022

Pelvipharm at the 24th Annual Fall Scientific Meeting in San Diego, USA, 16-19 November, 2023. François Giuliano will present one abstract :  “Overview of nonclinical studies of LIB-01, a novel promising oral drug under development for treatment of erectile dysfunction”. François Giuliano, Diane Gorny, Mahita Razanakolona, Delphine Behr-Roussel, Rana Assaly, Charlotta Gauffin Please come and see us, we will be happy…

Read More

Presentations at the WCE 2023

Sep 25, 2022

Pelvipharm at the 15th World Congress on Endometriosis in Edinburg, May 3rd-6th, 2023.   Delphine Behr-Roussel  will present : ” Effect of estrous cycle stage on establishment of a endometriosis rodent model to evaluate the effect of new therapeutic strategies ” R. Assaly, S. Compagnie, L. Allimonnier, M. Bracconi, F. Giuliano, L. Alexandre, D. Behr-Roussel.   Please come and…

Read More

Presentation at the ICS 2023

Sep 23, 2022

Presentation at the International Continence Society in Toronto, September 27th-29th, 2023. Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm: ” Intravesical administration of EG110A, a novel nonreplicative Herpes Simplex Virus (HSV-1)-derived vector expressing the light chain of botulinum toxin F, inhibits C-type fibers in an acute intravesical capsaicin rat model ” Ratelade J1, Faugeroux J2, Behr-Roussel…

Read More
logo_ok
UFR Simone Veil - Santé
Université de Versailles St Quentin en Yvelines
2 Avenue de la Source de la Bièvre - 78180 Montigny-Le-Bretonneux FRANCE